Vyteris has assembled a very talented group of advisors from industry and academia to act as key consultants to our business. The group is designed to guide the company through existing and new therapeutic markets as well as support our technological advancements in drug delivery systems. The members of our Scientific Advisory Board are:

Richard Guy, Ph.D., is currently Professor and Scientific Director, Pharmapeptides, Inter-University Center for Research and Teaching, University of Geneva. His career has been focused in the areas of skin barrier function characterization, transdermal drug delivery, iontophoresis, and the prediction and assessment of skin penetration and topical bioavailability. Dr. Guy has also been instrumental in researching and understanding a process known as reverse iontophoresis. He is currently the President of the Controlled Release Society. Dr. Guy is an elected fellow of the Royal Society of Chemistry, American Association of Pharmaceutical Scientists and the American Association of the Advancement of Science. He serves on the editorial advisory board of Advanced Drug Delivery Reviews, Journal of Controlled Release, Journal of Pharmacy and Pharmacology, He is also a scientific advisor to several companies in the pharmaceutical and biotechnology industries. Dr. Guy has published over 200 articles in the area of transdermal drug delivery.

Brian Hoffman, M.D., is currently Chief of Medicine at Boston Veterans Administration Hospital and Professor of Medicine at Harvard Medical School. He has authored over 150 - articles on a wide range of topics related to clinical and molecular pharmacology. Dr. Hoffman is a member of the American Federation of Medical Research and the American Society for Clinical Pharmacology and Therapeutics. He serves on the editorial board of the Journal of Pharmacology and Experimental Therapeutics and Journal of Cardiovascular Pharmacology.

Howard Maibach, M.D., is the Professor and Vice Chair of the Department of Dermatology at the University of California, San Francisco. During his career Dr. Maibach has held numerous positions in the field of dermatology and pioneered research in the area of dermatotoxicology. Dr. Maibach has held frequent teaching and consulting positions, and is a well-known participant in the lecture circle. He is a member of American College of Physicians, American Academy of Dermatology, American Medical Association, American Society of Clinical Pharmacology and Therapeutics, American Dermatological Association, American Federation of Clinical Research. He is on the editorial board of a number of journals including International Journal of Dermatology, Clinical Toxicology, Recent Advances in Dermatology, Journal of Clinical Research and Pharmacoepidemiology, Journal of European academy of Dermatology and Venereology, Journal of Applied Toxicology, Clinical Therapeutic, etc. He has published over 1600 articles dealing with various dermatological topics.

Russell Owen Potts, Ph.D., Dr. Potts is a recognized expert in the field of iontophoresis. Most recently he served as Vice President of Research and Development at Cygnus, Inc. where he was instrumental in the development and commercialization of Glucowatch Biographer - a transdermal diagnostic system to continuously monitor blood glucose levels in patients with diabetes. He has published a substantial body of literature including book chapters on various iontophoresis related subjects and in the field of skin biophysics. He is currently on the editorial boards of the Journal of Drug Delivery and the Journal of Controlled Release. He has been involved in the creation of several inventions in the field of iontophoresis and holds 15 US patents. He received his Ph.D. in Biochemistry from the University of Massachusetts, Amherst, his M.S. in Physical Chemistry from Cornell University, and his B.S. in Chemistry from Michigan State University. He is currently a consultant to the healthcare industry in the field of medical devices and pharmaceuticals.

Randall Jay Mrsny, Ph.D., Dr. Mrsny is a recognized expert in the field of drug delivery. Most recently he served as the head of Drug Delivery and Biology Group at Genentech Inc. and was involved in the evaluation and characterization of technologies involving alternate methods of drug delivery. He was previously at ALZA Corp. where he led the Peptide Biology Laboratory for three years. He has published an extensive body of literature in the field of drug delivery and mechanisms related to protein and peptide delivery. He serves on the editorial advisory boards of the Pharmaceutical Research and the Journal of Drug Targeting. He obtained his Ph.D. in Anatomy and Cell Biology at the University of California Davis School of Medicine and obtained his B.S. degree in Biochemistry and Biophysics at the University of California at Davis. After his doctorate, he spent four years as an NIH Postdoctoral Fellow in Membrane Biophysics at the Institute of Molecular Biology at the University of Oregon. He is currently a Professor of Drug Delivery and Biology at Cardiff University in Wales, UK and also a founder and Chief Scientific Officer of a new drug delivery company, Trinity Biosystems, in Los Altos Hills, California. He has been serving on the scientific advisory board of Syntonix Pharmaceuticals since 2000. At Cardiff University, he has been conducting research in the uptake and targeting of pharmaceutically relevant proteins and peptides.

Vilambi NRK Reddy, Ph.D. Dr. Reddy is a recognized expert in the field of iontophoretic drug delivery. Most recently he served as the Director of Product development at Becton Dickinson Transdermal Systems where he led the design and development of the first pre- filled iontophoretic Lidocaine/Epinephrine drug delivery system. He was also instrumental in the development of several core technologies and materials for use in the development of commercializable iontophoretic drug delivery systems with high currents and for long duration of application. His professional interests include product development, materials engineering, applied research and electrochemical systems design and development. He has been involved in the creation of several inventions in the field of iontophoresis and holds 15 US patents. He received his Ph.D. in (Electro)Chemical Engineering from Clarkson University, Potsdam, NY, his M.S. in Chemical Engineering from Clarkson University, Potsdam, NY, his (M.S.) in Manufacturing Engineering from University of Lowell, Lowell, MA and his B.Tech in Chemical Engineering from University of Madras, India. He is currently a consultant to the healthcare industry in the field of Transdermal drug delivery.

Back to topTop
 
Home Company Technology Products Partnering Careers News
 
© 2003 Vyteris. All Rights Reserved.